The efficacy of wait and see policy in rectal cancer for clinical complete responders after neoadjuvant chemoradiotherapy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002488

Enrollment

Unknown

Registered

2012-09-04

Start date

2012-09-04

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

surgery group:surgery

waiting list:observation

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pathological confirmed rectal adenocarcinoma before treatment; 2. Clinical stage II-III (cT3N0M0 or TanyN+M0); 3. Complete response after chemoradiation; 4. Distal rectum (0-7 cm from anal verge); 5. Age=70; 7. Voluntarily participate the study.

Exclusion criteria

Exclusion criteria: 1. Other cancer history in the past 5 years; 2. Grade 3-4 toxicity of chemoradiotherapy; 3. Die of non-cancer reasons; 4. Lose follow-up within the first year.

Design outcomes

Primary

Measure	Time frame
progression rate;5-year disease free survival;5-year overall survival;	—

Secondary

Measure	Time frame
the surgery rate in the waiting list and observation;	—

Contacts

Public ContactJin Gu

zlguj@yahoo.com.cn+86 13801180717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026